Sarcopenia in Chronic Lung Diseases

NCT06280443 | Recruiting

• 1 other identifier: CE22407B
• Study Type: observational
• Target: 300
• Locations: 1 country
• Sites: 1

Brief Summary

Inclusion criteria A)Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment. B) Patients who agree to provide the ID card number to the research team for usage as a link to the National Health Insurance research database and Health bank to explore the continuity of care and the use of medical resources

Conditions

Sarcopenia; COPD; Asthma; ILD

Outcome Measures

Primary Outcomes (1)

• sarcopenia rate

  The proportion of sarcopenia diagnosis in patients with chronic lung diseases

  1 year

Eligibility Criteria

• Age: 20 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

* Baseline demographic characteristic, health behavior and exercise habits are collected by questionnaires.The main disease diagnosis, medication, clinical assessment questionnaire or biochemical examination and radiological examination results in outpatient visit are collected. * According to the 2019 Asian Sarcopenia Consensus, participants are examined by SARC-Calf questionnaire, grip strength test, frailty index and a physical performance test,including sit-stand test, short physical performance battery (SPPB), gait speed test and six-minute walk test. Afterward, bioelectrical impedance analysis (BIA) are applied to all participants by to analyze body composition. Participants are classified into Sarcopenia group and severe Sarcopenia group.

You may qualify if:

• Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment.
• Those who meet the conditions for frailty diagnosis after assessment by the Frailty Scale
• Patients who agree to provide the ID card number to the research team for usage as a link to the National Health Insurance research database and Health bank to explore the continuity of care and the use of medical resources
• Age\>=20

You may not qualify if:

• Patients who refuse to sign the consent form
• Patients who are bed ridden or unable to walk due to physical disabilities
• Patients with terminal cancer or human acquired immunodeficiency syndrome
• Patients with edema (pitting edema +2)

Sponsors & Collaborators

• Taichung Veterans General Hospital: lead

Study Sites (1)

Taichung Veterans General Hospital

Taichung, 40705, Taiwan

RECRUITING

MeSH Terms

Conditions

Sarcopenia; Pulmonary Disease, Chronic Obstructive; Asthma

Condition Hierarchy (Ancestors)

Muscular Atrophy; Neuromuscular Manifestations; Neurologic Manifestations; Nervous System Diseases; Atrophy; Pathological Conditions, Anatomical; Pathological Conditions, Signs and Symptoms; Signs and Symptoms; Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Bronchial Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Central Study Contacts

Pin-Kuei Fu

CONTACT

04-23592525; fpk113@gmail.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: February 20, 2024
• First Posted: February 28, 2024
• Study Start: November 25, 2022
• Primary Completion: October 13, 2024
• Study Completion (Estimated): September 30, 2032
• Last Updated: April 4, 2024

Record last verified: 2024-04

Locations

TW (1)